Tolerability and Efficacy of CBD Extract for RLS Treatment
Status:
NOT_YET_RECRUITING
Trial end date:
2026-02-25
Target enrollment:
Participant gender:
Summary
This study plans to learn more about the safety and tolerability of cannabinoids, cannabidiol (CBD) and cannabigerol (CBG), for use in Idiopathic Restless Legs Syndrome. Symptoms and side effects experienced while taking the study drug will be tracked to determine if this medication is safe to use.
Phase:
PHASE2
Details
Lead Sponsor:
University of Colorado, Denver
Collaborators:
Biopharmaceutical Research Company BRC Therapeutics